Variant report

Variant	esv19278
Chromosome Location	chr16:79835005-79837826
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WWOX-2	chr16:79835070-79835240	ENSG00000260876.1

Extended variants
information (count: 189 )
Associated
traits (count: 69 )

Variant overlapped rSNPs/rCNVs (count:189 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs546835774	chr16:79835010-79835011	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs568322850	chr16:79835025-79835026	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs7187906	chr16:79835033-79835034	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
4	rs149178967	chr16:79835061-79835062	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs74037487	chr16:79835071-79835072	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs539494533	chr16:79835094-79835095	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
7	rs551159351	chr16:79835096-79835097	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
8	rs4538028	chr16:79835130-79835131	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs74608004	chr16:79835133-79835134	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
10	rs577692649	chr16:79835137-79835138	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
11	rs555543193	chr16:79835143-79835144	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
12	rs4392086	chr16:79835160-79835161	Weak transcription	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
13	rs538197155	chr16:79835171-79835172	Weak transcription	lncRNA	n/a	Overlapped CNVs	n/a
14	rs143404335	chr16:79835210-79835211	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
15	rs577981005	chr16:79835218-79835219	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
16	rs79630054	chr16:79835223-79835224	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
17	rs146867633	chr16:79835234-79835235	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
18	rs78140384	chr16:79835299-79835300	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs79910014	chr16:79835329-79835330	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs73572258	chr16:79835336-79835337	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs561902293	chr16:79835338-79835339	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs529184584	chr16:79835339-79835340	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs140707639	chr16:79835371-79835372	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs562820142	chr16:79835403-79835404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs537569464	chr16:79835405-79835406	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs573975420	chr16:79835410-79835411	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs370512518	chr16:79835415-79835416	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs4299168	chr16:79835428-79835429	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs551366283	chr16:79835467-79835468	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs566181949	chr16:79835481-79835482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs552573564	chr16:79835485-79835486	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs377534378	chr16:79835490-79835491	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs549156947	chr16:79835495-79835496	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs567555390	chr16:79835505-79835506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs7191989	chr16:79835516-79835517	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs540008076	chr16:79835526-79835527	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs556551650	chr16:79835543-79835544	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs145652581	chr16:79835546-79835547	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs138208339	chr16:79835559-79835560	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs141911542	chr16:79835576-79835577	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs114340068	chr16:79835582-79835583	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs543175706	chr16:79835616-79835617	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs117077271	chr16:79835629-79835630	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs150207673	chr16:79835634-79835635	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs368823321	chr16:79835660-79835661	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs138047356	chr16:79835676-79835677	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs542530416	chr16:79835685-79835686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs561987732	chr16:79835757-79835758	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs533259912	chr16:79835761-79835762	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs181703733	chr16:79835795-79835796	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:69)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Adrenocortical carcinoma	18281524	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Hypoplastic left heart syndrome	22349727	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Schizophrenia	21346763	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:13 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:79814000-79839600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr16:79831200-79839400	Weak transcription	Fetal Lung	lung
3	chr16:79834600-79835200	Weak transcription	Thymus	Thymus
4	chr16:79834600-79838400	Weak transcription	K562	blood
5	chr16:79835200-79835400	Enhancers	Thymus	Thymus
6	chr16:79835400-79835800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr16:79835400-79836400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr16:79835400-79839600	Weak transcription	Thymus	Thymus
9	chr16:79835600-79836000	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr16:79835600-79836200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
11	chr16:79836000-79836200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
12	chr16:79836000-79838800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
13	chr16:79836200-79842400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links